NDUFAF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.137000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.698000E-01
Normal-vs-Stage2
5.145800E-01
Normal-vs-Stage3
2.153200E-01
Normal-vs-Stage4
9.897600E-01
Stage1-vs-Stage2
8.970400E-01
Stage1-vs-Stage3
4.967200E-01
Stage1-vs-Stage4
5.384200E-01
Stage2-vs-Stage3
3.915400E-01
Stage2-vs-Stage4
1.394410E-02
Stage3-vs-Stage4
1.615390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.660400E-01
Normal-vs-AfricanAmerican
5.806800E-01
Normal-vs-Asian
7.545000E-01
Caucasian-vs-AfricanAmerican
5.172100E-02
Caucasian-vs-Asian
6.087200E-01
AfricanAmerican-vs-Asian
3.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.367000E-01
Normal-vs-Female
5.104000E-01
Male-vs-Female
9.434000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.839560E-01
Normal-vs-Age(41-60Yrs)
4.413800E-01
Normal-vs-Age(61-80Yrs)
5.607200E-01
Normal-vs-Age(81-100Yrs)
7.373400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.104200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.830600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.567770E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.871600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.616400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.938400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.338000E-01
Normal-vs-Daily Drinker
3.346200E-01
Normal-vs-Weekly Drinker
8.705600E-01
Normal-vs-Occasional Drinker
3.075000E-01
Normal-vs-Social Drinker
6.172800E-01
Non Drinker-vs-Daily Drinker
8.385600E-01
Non Drinker-vs-Weekly Drinker
2.438200E-01
Non Drinker-vs-Occasional Drinker
8.517200E-01
Non Drinker-vs-Social Drinker
6.168800E-01
Daily Drinker-vs-Weekly Drinker
2.396000E-01
Daily Drinker-vs-Occasional Drinker
7.194800E-01
Daily Drinker-vs-Social Drinker
5.518400E-01
Weekly Drinker-vs-Occasional Drinker
3.729600E-01
Weekly Drinker-vs-Social Drinker
6.090800E-01
Occasional Drinker-vs-Social Drinker
7.408200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.104800E-01
Normal-vs-Grade 2
6.506400E-01
Normal-vs-Grade 3
8.655000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.086400E-01
Grade 1-vs-Grade 3
2.276800E-01
Grade 1-vs-Grade 4
6.104800E-01
Grade 2-vs-Grade 3
3.197600E-01
Grade 2-vs-Grade 4
6.506400E-01
Grade 3-vs-Grade 4
8.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.373800E-01
Normal-vs-NonDiabetic
4.339000E-01
Diabetic-vs-NonDiabetic
8.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.485770E-01
Normal-vs-NoPancreatitis
4.752400E-01
Pancreatitis-vs-NoPancreatitis
1.732580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.529800E-01
Normal-vs-N1
4.895800E-01
N0-vs-N1
5.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.570000E-01
Normal-vs-TP53-NonMutant
8.140000E-01
TP53-Mutant-vs-TP53-NonMutant
1.302280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
